DIGOXIN injection indications and usage: Difference between revisions
(Created page with "__NOTOC__ {{Digoxin}} {{CMG}}; {{AE}} {{AK}} '''''For patient information, click <u>here'''''</u>. ==1 INDICATIONS AND USAGE== ===1.1 Hear...") |
No edit summary |
||
| Line 10: | Line 10: | ||
Digoxin injection USP is indicated for the treatment of mild to moderate [[heart failure ]]in adults. Digoxin injection USP increases left ventricular [[ejection fraction]] and improves [[heart failure]] symptoms, as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, digoxin injection USP should be used in combination with a [[diuretic]] and an [[angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme (ACE) inhibitor]]. | Digoxin injection USP is indicated for the treatment of mild to moderate [[heart failure ]]in adults. Digoxin injection USP increases left ventricular [[ejection fraction]] and improves [[heart failure]] symptoms, as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, digoxin injection USP should be used in combination with a [[diuretic]] and an [[angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme (ACE) inhibitor]]. | ||
1.2 Heart Failure in Pediatric Patients | ===1.2 Heart Failure in Pediatric Patients=== | ||
Digoxin injection USP increases myocardial contractility in pediatric patients with heart failure. | Digoxin injection USP increases myocardial contractility in pediatric patients with heart failure. | ||
1.3 Atrial Fibrillation in Adults | ===1.3 Atrial Fibrillation in Adults=== | ||
Digoxin injection USP is indicated for the control of ventricular response rate in adult patients with chronic [[atrial fibrillation]]. | Digoxin injection USP is indicated for the control of ventricular response rate in adult patients with chronic [[atrial fibrillation]]. | ||
==References== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58f45aba-ff6f-43cc-bb88-be40a9f7beda | http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58f45aba-ff6f-43cc-bb88-be40a9f7beda | ||
Revision as of 19:39, 27 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
For patient information, click here.
1 INDICATIONS AND USAGE
1.1 Heart Failure in Adults
Digoxin injection USP is indicated for the treatment of mild to moderate heart failure in adults. Digoxin injection USP increases left ventricular ejection fraction and improves heart failure symptoms, as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, digoxin injection USP should be used in combination with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor.
1.2 Heart Failure in Pediatric Patients
Digoxin injection USP increases myocardial contractility in pediatric patients with heart failure.
1.3 Atrial Fibrillation in Adults
Digoxin injection USP is indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation.
References
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58f45aba-ff6f-43cc-bb88-be40a9f7beda